You have 9 free searches left this month | for more free features.

Recombinant Human Hyaluronidase

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AL Amyloidosis Trial (procedure, drug, other)

Not yet recruiting
  • AL Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +15 more
  • (no location specified)
Aug 28, 2023

Health, Subjective Trial in Seoul (BMI2004, 0.9% NaCl)

Completed
  • Health, Subjective
  • BMI2004
  • 0.9% NaCl
  • Seoul, Heukseok-ro, Dongjak-gu, Korea, Republic of
    Chung-Ang University Hospital
Jun 26, 2023

Exposure During Pregnancy Trial in Worldwide (A licensed human normal immunoglobulin other than HYQVIA for IV or SC infusion or

Completed
  • Exposure During Pregnancy
  • A licensed human normal immunoglobulin other than HYQVIA for IV or SC infusion or an alternative treatment
  • HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase]
  • Durham, North Carolina
  • +7 more
Apr 2, 2021

Primary Immunodeficiency Diseases (PID) Trial in United States (SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC,

Completed
  • Primary Immunodeficiency Diseases (PID)
  • SC treatment with IGSC, 10% with rHuPH20 followed by SC/IGSC, 10% only (safety)
  • +2 more
  • Cypress, California
  • +10 more
Apr 30, 2021

Hepatic Ascites Trial in Guangdong (Recombinant Human Serum Albumin, Human serum albumin)

Not yet recruiting
  • Hepatic Ascites
  • Recombinant Human Serum Albumin
  • Human serum albumin
  • Guangdong, Shenzhen, China
    Shenzhen Protgen Ltd
May 5, 2023

Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

Not yet recruiting
  • Advanced Mucosal Melanoma
  • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
  • (no location specified)
Sep 15, 2023

Chronic Lymphocytic Leukemia Trial in Washington, Hackensack (Venetoclax, Rituximab, Rituximab/Hyaluronidase Human)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Washington, District of Columbia
  • +1 more
Mar 14, 2022

Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

Enrolling by invitation
  • Malignant Melanomas
  • Recombinant Human Adenovirus Type 5 Injection
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023

Nasopharyngeal Carcinoma Trial (Envafolimab and recombinant human endostatin combined with chemoradiotherapy)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Envafolimab and recombinant human endostatin combined with chemoradiotherapy
  • (no location specified)
Sep 23, 2023

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

Suspended
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in

Recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +13 more
  • Polatuzumab Vedotin
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Aug 23, 2022

Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)

Not yet recruiting
  • Advanced Solid Tumors
  • Recombinant human IL-21 oncolytic vaccinia virus injection
  • Hangzhou, Zhejiang, China
  • +1 more
Jun 21, 2023

Chronic Inflammatory Demyelinating Polyradiculoneuropathy Trial in Worldwide (HYQVIA, 0.25% albumin solution with rHuPH20,

Completed
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy
  • HYQVIA
  • +2 more
  • Phoenix, Arizona
  • +82 more
Feb 28, 2022

Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula

Not yet recruiting
  • Norovirus Infections
  • Norwalk Gastroenteritis
  • Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine,Recombinant (Hansenula polymorpha)
  • placebo
  • (no location specified)
Jun 14, 2023

Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before

Not yet recruiting
  • Herpes Zoster
  • Recombinant Human Interferon α-2b Gel (After the Alteration)
  • Recombinant Human Interferon α-2b Gel (Before the Alteration)
  • (no location specified)
Apr 7, 2023

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Houston (Pegylated Recombinant Human

Withdrawn
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Pegylated Recombinant Human Hyaluronidase PH20
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Mar 11, 2020

Viral Upper Respiratory Tract Infection Trial (recombinant human interferon ? spray)

Not yet recruiting
  • Viral Upper Respiratory Tract Infection
  • recombinant human interferon ω spray
  • (no location specified)
May 7, 2023

Acute Gout Trial in Nanchang (rhTNFR-Fc, Triamcinolone Acetonide)

Not yet recruiting
  • Acute Gout
  • Nanchang, Jiangxi, China
    Department of Rheumatology and Clinical Immunology, Jiangxi Prov
Jun 28, 2023

Shoulder Pain, Neck Pain, Back Pain Trial in Qingdao (HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly

Completed
  • Shoulder Pain
  • +4 more
  • HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
  • Qingdao, Shandong, China
    Qingdao University Affiliated Hospital
Mar 1, 2023

Advanced Solid Tumor, Refractory Tumor Trial in Suzhou (Radiotherapy, PD-1/PD-L1 inhibitor, Granulocyte-macrophage

Recruiting
  • Advanced Solid Tumor
  • Refractory Tumor
  • Radiotherapy
  • +4 more
  • Suzhou, China
    The Second Affiliated Hospital of SchoowUniversity
Sep 14, 2023

Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Rituximab and Hyaluronidase Human
  • +8 more
  • Kampala, Uganda
    UCI-Fred Hutch Cancer Centre
Mar 9, 2022

Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Hypertension, Diabetes, Blood Disease Trial in Baghdad (rhBMP-2)

Recruiting
  • Hypertension
  • +2 more
  • rhBMP-2
  • Baghdad, Alresafa, Iraq
    University of Baghdad
Jan 31, 2023

NSCLC, Gastric Cancer Trial in United States (PEGPH20, Pembrolizumab)

Completed
  • NSCLC
  • Gastric Cancer
  • Birmingham, Alabama
  • +27 more
Jan 24, 2020

Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Recombinant Interleukin-7
  • Houston, Texas
    M D Anderson Cancer Center
Jan 26, 2023